PT-141 10mg

  • FDA-Approved Melanocortin Agonist: Cyclic heptapeptide MC3R/MC4R agonist, approved June 2019 (Vyleesi) for premenopausal HSDD, 100+ publications, first melanocortin therapeutic for sexual function
  • CNS Mechanism: Crosses blood-brain barrier, activates hypothalamic MC4R in mPOA triggering dopamine release, melanocortin-dopamine integration, mesolimbic reward pathway modulation
  • Clinical Development: 43 completed trials with 3,500+ subjects, Phase 3 RECONNECT (n=1,267) showed +0.35 desire improvement, 58% vs 36% responder rates, well-characterized safety profile
Manufacturer: RiboCore
Availability: In stock
SKU: RC-PT-141-10MG
$33.25
Ship to
*
*
Shipping Method
Name
Estimated Delivery
Price
No shipping options
PT-141 10mg PT-141 10mg PT-141 is a synthetic melanocortin receptor agonist structurally derived from the analog Melanotan II. It binds selectively to MC3R and MC4R, modulating neuropeptide signaling pathways involved in hypothalamic control mechanisms. PT-141 is commonly employed in research focusing on GPCR activation, neuronal signaling, and neuroendocrine modulation. For research use only. Not for human consumption. References: Wessells H et al., J Urol, 2003 170(2 Pt 1):627–632 Shadiack AM et al., J Sex Med, 2007 4(1):95–104 Hadley ME, Ann NY Acad Sci, 2006 994:419–430 $55.00 Products will arrive in a lyophilized (powder) form for maximum stability Add to Cart Buy 3 and save 4% $53.00 each Buy 5 and save 6% $52.00 each Buy 10 and save 10% $50.00 each Categories Peptide Capsules 5-Amino-1MQ 50mg (60 Capsules) BPC-157 500mcg (60 Capsules) Dihexa 5mg (60 Capsules) Epitalon Capsules (Telomere Length) 1mg (60 Capsules) GHK-Cu Capsules (Copper Tripeptide) 2mg (60 Capsules) Gut Inflammat
Only registered users can write reviews